Hypereosinophilia in the intensive care setting

Authors

  • Antoine GAILLET Créteil Univ1. Service de Médecine intensive et réanimation, Hôpital Universitaire Bichat - Claude-Bernard, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, France. 2. National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151 Suresnes Cedex, Franceersity
  • Matthieu Groh Department of Internal Medicine, Foch Hospital, Suresnes, France.

DOI:

https://doi.org/10.37051/mir-34-002169

Keywords:

Eosinophilia, Hypereosinophilia, Hypereosinophilic syndrome, Intensive care unit

Abstract

Hypereosinophilia (HE) (> 1.5 x 109/L) is not rare and should not be neglected in life-threatening emergencies. Rather, HE (whatever the underlying cause) can be responsible for life and/or organ-threatening manifestations (especially in case of cardiac, respiratory, vascular, or neurologic involvement). Complementary investigations should be tailored according to the timing of onset of HE and to the severity of symptoms. In case of organ or life-threatening organ involvement induced by HE, the etiological workup should not delay the implementation of emergency therapies (i.e., corticosteroids, antiparasitic drugs +/- anticoagulants), along with the treatment of the underlying condition whenever possible.

Image

Published

2026-03-31

How to Cite

GAILLET, A., & Groh, M. (2026). Hypereosinophilia in the intensive care setting. Médecine Intensive Réanimation, 35(1). https://doi.org/10.37051/mir-34-002169

Most read articles by the same author(s)